Senior Director, Patient Support Services

Market Development Cambridge, MA


Description

Who are we?

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron’s leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Acceleron focuses its commercialization, research, and development efforts in hematologic and pulmonary diseases. In hematology, REBLOZYL® (luspatercept-aamt) is the first and only erythroid maturation agent approved in the United States and Europe for the treatment of anemia in certain blood disorders. REBLOZYL is part of a global collaboration partnership with Bristol Myers Squibb. The Companies co-promote REBLOZYL in the United States and are also developing luspatercept for the treatment of anemia in patient populations of MDS, beta-thalassemia, and myelofibrosis. In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension, having recently reported positive topline results of the Phase 2 PULSAR trial.

For more information, please visit www.acceleronpharma.com. Follow Acceleron on Social Media: @AcceleronPharma and LinkedIn.

What’s in it for you?

The Sr. Director, Patient Services will operationalize Sotatercept and future products US commercial patient support programs by aligning with Acceleron values, assessing patient support needs, defining objectives and measurements, and executing programs, including reimbursement hub, co-pay, and any additional support programs. This individual also will be responsible for sourcing and managing vendor contracts and overseeing project budgets. She/He will work closely with several departments including but not limited to US Marketing, Sales, Market Access, Commercial Operations, Regulatory, Legal, Compliance, and external customers. This is an excellent opportunity to join a high performing team committed to making a difference in the lives of patients.

 

What will you be doing?

  • Lead the development and management of Sotatercept US commercial patient support and co-pay programs and ensure alignment with patient needs and Acceleron company values
  • Lead the design and implementation of a patient support HUB
  • Develop and maintain SOPs and business rules related to US patient support
  • Hire and onboard an industry leading of patient navigators
  • Manage strategic advisors and vendors in support of the operation, including vendor selection contracts, SOPs, reporting requirements, and budgets
  • Define measurement of patient support program performance
  • Partner with Commercial Operations to ensure accurate and efficient reporting on key metrics
  • Work cross-functionally, as well as with compliance and legal departments, to ensure all training responsibilities, policies, and procedures are met
  • Manage daily operations of the service model and identifies areas for process improvement

What are we looking for?

  • Bachelors’ degree, MBA or other advanced degree preferred, and a minimum of 15 years of experience in patient support, US in-line market access, or marketing in the Pharmaceutical/Biotechnology industry
  • In depth knowledge of pharmaceutical manufacturer compliance requirements, HIPAA regulations
  • Knowledge and experience in Medicare Part D, Medicaid and private payer policies, reimbursement process, Foundations and specialty pharmacy
  • New product launch experience with a specialty pharmacy product
  • Experience leading and influencing large cross-functional teams
  • Experience managing customer facing vendors
  • Excellent leadership skills and the ability to inspire, coach, motivate and hold themselves and others accountable
  • Strong communication skills, both written and verbal
  • Entrepreneurial spirit, the ability to foster relationships, and the ability to develop innovative ideas and solutions
  • Excellent project management and prioritization skill
  • Demonstrated ability to manage multiple projects within specified timelines, budgetary and quality standards
  • May require up to 30% travel based on business need

*In compliance with federal law, all persons hired will be required to verify identity and eligibility to work in the United States and complete the required employment eligibility verification document form upon hire.

*Recruiters - please do not send unsolicited resumes to this posting.

FOR IMMEDIATE CONSIDERATION PLEASE SUBMIT YOUR RESUME TO:

www.acceleronpharma.com

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron’s leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair. Acceleron focuses its research, development, and commercialization efforts in pulmonary and hematologic diseases. In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension (PAH), having reported positive topline results of the PULSAR Phase 2 trial. The Company is currently planning multiple Phase 3 trials with the potential to support its long-term vision of establishing sotatercept as a backbone therapy for patients with PAH at all stages of the disease. Acceleron is also investigating the potential of its early-stage pulmonary candidate, ACE-1334, which it plans to advance into a Phase 1b/2 trial in systemic sclerosis-associated interstitial lung disease (SSc-ILD) next year. In hematology, REBLOZYL® (luspatercept-aamt) is the first and only erythroid maturation agent approved in the United States, Europe, and Canada for the treatment of anemia in certain blood disorders. REBLOZYL is part of a global collaboration partnership with Bristol Myers Squibb. The Companies co-promote REBLOZYL in the United States and are also developing luspatercept for the treatment of anemia in patient populations of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis. For more information, please visit www.acceleronpharma.com. Follow Acceleron on Social Media: @AcceleronPharma and LinkedIn.